Surgical treatment of hypertrophic cardiomyopathy: what’s new?

Journal Title: Серце і судини - Year 2018, Vol 0, Issue 2

Abstract

The aim — to investigate the effectiveness of surgical septal myectomy in patients with obstructive form of hypertrophic cardiomyopathy (HCM) and to determine its effect on survival and quality of life. Materials and methods. The research included 118 consequential symptomatic patients with obstructive form of HCM who underwent surgical extensive myectomy with secondary chordae resection and mobilization of the anterior and posterior groups of papillary muscles (PM). An evaluation of the following parameters in group of patients before and after surgical intervention was performed: systolic pressure gradient (SPG) on the left ventricle outflow tract (LVOT), mitral regurgitation (MR) degree, NYHA functional class, survival rate and main post­operative complications. Results and discussion. According to the obtained data, SPG decreased from 93.6 ± 23.2 mmHg prior the surgery to 19.7 ± 11.4 mmHg after the treatment (p < 0.001). 21 (17.8 %) patients had moderate degree of MR after the surgery, while before the intervention the number of patients who had moderate or severe MR degree made up 101 (85.5 %) out of 118 (p < 0.001). Out of 118 patients, 36 (30.5 %) of whom had III — IV NYHA functional class of heart failure before the procedure, 115 (97.4 %) switched to functional class I — II in the latest follow­up (p < 0.001). The mortality accounted for 1.7 %. Out of 118 patients under study, one (0.8 %) underwent cardioverter­defibrillator implantation in the post­operative period for the prophilaxis of sudden death, and 5 (4.2 %) patients underwent pacemaker implantation due to complete post­operative AV­block. Conclusions. Surgical septal myectomy by professor P. Ferrazzi procedure is a gold standard of treatment of patients with obstructive form of HCM. Successful correction of HCM can be conducted only by a high­qualified surgeon with experience of reconstruction of valvular pathologies and in an expert center, where it is possible to perform routine pre­operative MRI or CT‑planning and mandatory intraoperative echocardiographic control.

Authors and Affiliations

V.   V. Lazoryshynets, K.   V. Rudenko, O.  A. Krykunov, A.  O. Rusnak, O.  M. Trembovetska, L.  O. Nevmerzhytska, P.  A. Danchenko

Keywords

Related Articles

Surgical treatment of hypertrophic cardiomyopathy: what’s new?

The aim — to investigate the effectiveness of surgical septal myectomy in patients with obstructive form of hypertrophic cardiomyopathy (HCM) and to determine its effect on survival and quality of life. Materials and me...

Clinical characterіstics and survival of hospitalized patients with chronic heart failure and reduced left ventricular ejection fraction depending on dynamics of nitrogen-releasing kidney function during period of overcoming clinical decompensation

The aim — to investigate the main clinical hemodynamic and laboratory characteristics in hospitalized patients with chronic heart failure (CHF), depending on the dynamics of the nitrogen‑releasing renal function during t...

Risk factors for death at long-term follow-up after acute coronary syndrome in patients with atrial fibrillation

The aim — to evaluate the predictive significance of clinical, instrumental and laboratory parameters regarding the mortality of patients with acute coronary syndrome (ACS) and atrial fibrillation (AF) at long‑term foll...

Actual methods of carotid body tumor diagnosis

The aim — to improve the carotid body tumors (CBT) diagnosis. Materials and methods. The article presents with the analysis of the structure and the results of the diagnosis and surgical treatment of 65 patients who were...

Growth differentiation factor 15 — biomarker of poor prognosis in heart failure

Heart failure (HF) is a major factor contributing to premature death in patients with established cardiovascular (CV) disease. There is a large body of evidence that biological markers, primarily natriuretic peptides, ga...

Download PDF file
  • EP ID EP332091
  • DOI 10.30978/HV201827
  • Views 120
  • Downloads 0

How To Cite

V.   V. Lazoryshynets, K.   V. Rudenko, O.  A. Krykunov, A.  O. Rusnak, O.  M. Trembovetska, L.  O. Nevmerzhytska, P.  A. Danchenko (2018). Surgical treatment of hypertrophic cardiomyopathy: what’s new?. Серце і судини, 0(2), 7-14. https://europub.co.uk/articles/-A-332091